Artificial Sweeteners and Risk of Type 2 Diabetes in the Prospective NutriNet-Santé Cohort.


Journal

Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975

Informations de publication

Date de publication:
01 09 2023
Historique:
received: 06 02 2023
accepted: 09 06 2023
medline: 28 8 2023
pubmed: 25 7 2023
entrez: 25 7 2023
Statut: ppublish

Résumé

To study the relationships between artificial sweeteners, accounting for all dietary sources (total and by type of artificial sweetener) and risk of type 2 diabetes (T2D), in a large-scale prospective cohort. The analyses included 105,588 participants from the web-based NutriNet-Santé study (France, 2009-2022; mean age 42.5 ± 14.6 years, 79.2% women). Repeated 24-h dietary records, including brands and commercial names of industrial products, merged with qualitative and quantitative food additive composition data, enabled artificial sweetener intakes to be accurately assessed from all dietary sources. Associations between artificial sweeteners (total, aspartame, acesulfame potassium [K], and sucralose) and T2D were investigated using Cox proportional hazard models adjusted for potential confounders, including weight variation during follow-up. During a median follow-up of 9.1 years (946,650 person-years, 972 incident T2D), compared with nonconsumers, higher consumers of artificial sweeteners (i.e., above the sex-specific medians of 16.4 mg/day in men and 18.5 mg/day in women) had higher risks of developing T2D (hazard ratio [HR] 1.69; 95% CI 1.45-1.97; P-trend <0.001). Positive associations were also observed for individual artificial sweeteners: aspartame (HR 1.63 [95% CI 1.38-1.93], P-trend <0.001), acesulfame-K (HR 1.70 [1.42-2.04], P-trend <0.001), and sucralose (HR 1.34 [1.07-1.69], P-trend = 0.013). Potential for reverse causality cannot be eliminated; however, many sensitivity analyses were computed to limit this and other potential biases. These findings of positive associations between artificial sweetener intakes and increased T2D risk strengthen the evidence that these additives may not be safe sugar alternatives. This study provides important insights in the context of on-going reevaluation of artificial sweeteners by health authorities worldwide.

Identifiants

pubmed: 37490630
pii: 153434
doi: 10.2337/dc23-0206
pmc: PMC10465821
doi:

Substances chimiques

Sweetening Agents 0
Aspartame Z0H242BBR1
acetosulfame MA3UYZ6K1H

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1681-1690

Informations de copyright

© 2023 by the American Diabetes Association.

Références

Stem Cell Res Ther. 2020 Jun 26;11(1):250
pubmed: 32586409
Cell. 2022 Sep 1;185(18):3307-3328.e19
pubmed: 35987213
BMC Public Health. 2010 May 11;10:242
pubmed: 20459807
Eur J Epidemiol. 2010 May;25(5):287-96
pubmed: 20191377
J Am Diet Assoc. 2009 Jun;109(6):1031-41
pubmed: 19465185
PLoS One. 2016 Aug 18;11(8):e0161264
pubmed: 27537496
BMJ. 2022 Sep 7;378:e071204
pubmed: 36638072
J Epidemiol Glob Health. 2020 Mar;10(1):107-111
pubmed: 32175717
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Clin Nutr ESPEN. 2017 Apr;18:1-8
pubmed: 29132732
J Epidemiol Community Health. 2015 Sep;69(9):893-8
pubmed: 25832451
BMJ. 2009 Jun 29;338:b2393
pubmed: 19564179
Diabetes Care. 2023 Mar 1;46(3):643-656
pubmed: 36812419
Eur J Nutr. 2020 Jun;59(4):1717-1727
pubmed: 31486878
JAMA Intern Med. 2020 Feb 1;180(2):283-291
pubmed: 31841598
Eur J Clin Nutr. 1991 Dec;45(12):569-81
pubmed: 1810719
Nutrients. 2018 Mar 15;10(3):
pubmed: 29543782
CMAJ. 2017 Jul 17;189(28):E929-E939
pubmed: 28716847
J Acad Nutr Diet. 2016 Mar;116(3):427-438.e5
pubmed: 26522988
Stat Med. 2010 Apr 30;29(9):1037-57
pubmed: 20087875
Nature. 2012 Oct 4;490(7418):55-60
pubmed: 23023125
Eur J Epidemiol. 2020 Jul;35(7):655-671
pubmed: 32529512
Br J Nutr. 2011 Apr;105(7):1055-64
pubmed: 21080983
Front Nutr. 2021 Jan 07;7:598340
pubmed: 33490098
Int J Obes Relat Metab Disord. 2000 Sep;24(9):1119-30
pubmed: 11033980
Int J Public Health. 2011 Aug;56(4):407-17
pubmed: 21538094
Eur J Clin Nutr. 2020 Feb;74(2):322-327
pubmed: 31253876
Br J Nutr. 2015 Mar 28;113(6):953-62
pubmed: 25772032
Sci Rep. 2021 Oct 4;11(1):19680
pubmed: 34608173
J Med Internet Res. 2013 Aug 08;15(8):e152
pubmed: 23928492

Auteurs

Charlotte Debras (C)

Nutritional Epidemiology Research Team (EREN), INSERM U1153, INRAE U1125, CNAM, Sorbonne Paris Nord University, Epidemiology and Statistics Research Centre, University of Paris Cité (CRESS), Bobigny, France.

Mélanie Deschasaux-Tanguy (M)

Nutritional Epidemiology Research Team (EREN), INSERM U1153, INRAE U1125, CNAM, Sorbonne Paris Nord University, Epidemiology and Statistics Research Centre, University of Paris Cité (CRESS), Bobigny, France.

Eloi Chazelas (E)

Nutritional Epidemiology Research Team (EREN), INSERM U1153, INRAE U1125, CNAM, Sorbonne Paris Nord University, Epidemiology and Statistics Research Centre, University of Paris Cité (CRESS), Bobigny, France.

Laury Sellem (L)

Nutritional Epidemiology Research Team (EREN), INSERM U1153, INRAE U1125, CNAM, Sorbonne Paris Nord University, Epidemiology and Statistics Research Centre, University of Paris Cité (CRESS), Bobigny, France.

Nathalie Druesne-Pecollo (N)

Nutritional Epidemiology Research Team (EREN), INSERM U1153, INRAE U1125, CNAM, Sorbonne Paris Nord University, Epidemiology and Statistics Research Centre, University of Paris Cité (CRESS), Bobigny, France.

Younes Esseddik (Y)

Nutritional Epidemiology Research Team (EREN), INSERM U1153, INRAE U1125, CNAM, Sorbonne Paris Nord University, Epidemiology and Statistics Research Centre, University of Paris Cité (CRESS), Bobigny, France.

Fabien Szabo de Edelenyi (F)

Nutritional Epidemiology Research Team (EREN), INSERM U1153, INRAE U1125, CNAM, Sorbonne Paris Nord University, Epidemiology and Statistics Research Centre, University of Paris Cité (CRESS), Bobigny, France.

Cédric Agaësse (C)

Nutritional Epidemiology Research Team (EREN), INSERM U1153, INRAE U1125, CNAM, Sorbonne Paris Nord University, Epidemiology and Statistics Research Centre, University of Paris Cité (CRESS), Bobigny, France.

Alexandre De Sa (A)

Nutritional Epidemiology Research Team (EREN), INSERM U1153, INRAE U1125, CNAM, Sorbonne Paris Nord University, Epidemiology and Statistics Research Centre, University of Paris Cité (CRESS), Bobigny, France.

Rebecca Lutchia (R)

Nutritional Epidemiology Research Team (EREN), INSERM U1153, INRAE U1125, CNAM, Sorbonne Paris Nord University, Epidemiology and Statistics Research Centre, University of Paris Cité (CRESS), Bobigny, France.

Chantal Julia (C)

Nutritional Epidemiology Research Team (EREN), INSERM U1153, INRAE U1125, CNAM, Sorbonne Paris Nord University, Epidemiology and Statistics Research Centre, University of Paris Cité (CRESS), Bobigny, France.
Public Health Department, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris, Bobigny, France.

Emmanuelle Kesse-Guyot (E)

Nutritional Epidemiology Research Team (EREN), INSERM U1153, INRAE U1125, CNAM, Sorbonne Paris Nord University, Epidemiology and Statistics Research Centre, University of Paris Cité (CRESS), Bobigny, France.

Benjamin Allès (B)

Nutritional Epidemiology Research Team (EREN), INSERM U1153, INRAE U1125, CNAM, Sorbonne Paris Nord University, Epidemiology and Statistics Research Centre, University of Paris Cité (CRESS), Bobigny, France.

Pilar Galan (P)

Nutritional Epidemiology Research Team (EREN), INSERM U1153, INRAE U1125, CNAM, Sorbonne Paris Nord University, Epidemiology and Statistics Research Centre, University of Paris Cité (CRESS), Bobigny, France.

Serge Hercberg (S)

Nutritional Epidemiology Research Team (EREN), INSERM U1153, INRAE U1125, CNAM, Sorbonne Paris Nord University, Epidemiology and Statistics Research Centre, University of Paris Cité (CRESS), Bobigny, France.
Public Health Department, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris, Bobigny, France.

Inge Huybrechts (I)

International Agency for Research on Cancer, World Health Organization, Lyon, France.

Emmanuel Cosson (E)

Nutritional Epidemiology Research Team (EREN), INSERM U1153, INRAE U1125, CNAM, Sorbonne Paris Nord University, Epidemiology and Statistics Research Centre, University of Paris Cité (CRESS), Bobigny, France.
Diabetology, Endocrinology and Nutrition Department, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris, Bobigny, France.

Sopio Tatulashvili (S)

Diabetology, Endocrinology and Nutrition Department, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris, Bobigny, France.

Bernard Srour (B)

Nutritional Epidemiology Research Team (EREN), INSERM U1153, INRAE U1125, CNAM, Sorbonne Paris Nord University, Epidemiology and Statistics Research Centre, University of Paris Cité (CRESS), Bobigny, France.

Mathilde Touvier (M)

Nutritional Epidemiology Research Team (EREN), INSERM U1153, INRAE U1125, CNAM, Sorbonne Paris Nord University, Epidemiology and Statistics Research Centre, University of Paris Cité (CRESS), Bobigny, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH